U.S. flag

An official website of the United States government

Display optionsSort by LocationDownload
Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 1575

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)		Review status
1.
GRCh37:
Chr17:33426507-33429871
GRCh38:
Chr17:35099488-35102852
RAD51D, RAD51L3-RFFLMalignant tumor of breastPathogenic
(Sep 1, 2020)		criteria provided, single submitter
2.
GRCh37:
Chr17:33426811-33430563
GRCh38:
Chr17:35099792-35103544
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Pathogenic
(Oct 17, 2016)		criteria provided, single submitter
3.
GRCh37:
Chr17:33426811-33428384
GRCh38:
Chr17:35099792-35101365
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Likely pathogenic
(Jan 16, 2017)		criteria provided, single submitter
4.
GRCh37:
Chr17:33427094-33427097
GRCh38:
Chr17:35100075-35100078
RAD51D, RAD51L3-RFFLBreast and Ovarian Cancer SusceptibilityUncertain significance
(Jun 14, 2016)		criteria provided, single submitter
5.
GRCh37:
Chr17:33427467-33428227
GRCh38:
Chr17:35100448-35101208
RAD51D, RAD51L3-RFFLS187fs, S299fs, S319fsBreast-ovarian cancer, familial, susceptibility to, 4Likely pathogenic
(Aug 26, 2022)		no assertion criteria provided
6.
GRCh37:
Chr17:33427467-33428227
GRCh38:
Chr17:35100448-35101208
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Likely pathogenic
(Oct 14, 2021)		criteria provided, single submitter
7.
GRCh37:
Chr17:33427538-33427539
GRCh38:
Chr17:35100519-35100520
RAD51D, RAD51L3-RFFLBreast and Ovarian Cancer SusceptibilityUncertain significance
(Jun 14, 2016)		criteria provided, single submitter
8.
GRCh37:
Chr17:33427842
GRCh38:
Chr17:35100823
RAD51D, RAD51L3-RFFLnot providedBenign
(Jun 21, 2018)		criteria provided, single submitter
9.
GRCh37:
Chr17:33427923
GRCh38:
Chr17:35100904
RAD51D, RAD51L3-RFFLnot specifiedLikely benign
(Aug 15, 2023)		criteria provided, single submitter
10.
GRCh37:
Chr17:33427956
GRCh38:
Chr17:35100937
RAD51L3-RFFL, RAD51DHereditary cancer-predisposing syndromeUncertain significance
(Apr 24, 2019)		criteria provided, single submitter
11.
GRCh37:
Chr17:33427958-33427960
GRCh38:
Chr17:35100939-35100941
RAD51D, RAD51L3-RFFLnot specifiedLikely benign
(Aug 2, 2016)		criteria provided, single submitter
12.
GRCh37:
Chr17:33427961
GRCh38:
Chr17:35100942
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeUncertain significance
(May 8, 2019)		criteria provided, single submitter
13.
GRCh37:
Chr17:33427962-33446642
GRCh38:
Chr17:35100943-35119623
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Jul 3, 2018)		criteria provided, single submitter
14.
GRCh37:
Chr17:33427962-33430573
GRCh38:
Chr17:35100943-35103554
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Pathogenic
(Oct 13, 2022)		criteria provided, single submitter
15.
GRCh37:
Chr17:33427962-33428065
GRCh38:
Chr17:35100943-35101046
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Likely pathogenic
(Aug 2, 2018)		criteria provided, single submitter
16.
GRCh37:
Chr17:33427962
GRCh38:
Chr17:35100943
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeLikely benign
(Oct 28, 2017)		criteria provided, single submitter
17.
GRCh37:
Chr17:33427965
GRCh38:
Chr17:35100946
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndrome, not specifiedConflicting interpretations of pathogenicity
(Nov 30, 2021)		criteria provided, conflicting interpretations
18.
GRCh37:
Chr17:33427966-33446638
GRCh38:
Chr17:35100947-35119619
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Feb 13, 2018)		criteria provided, single submitter
19.
GRCh37:
Chr17:33427966-33428061
GRCh38:
Chr17:35100947-35101042
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Likely pathogenic
(Apr 18, 2018)		criteria provided, single submitter
20.
GRCh37:
Chr17:33427968
GRCh38:
Chr17:35100949
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeUncertain significance
(Dec 15, 2020)		criteria provided, single submitter
21.
GRCh37:
Chr17:33427968
GRCh38:
Chr17:35100949
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndrome, not specifiedConflicting interpretations of pathogenicity
(May 15, 2017)		criteria provided, conflicting interpretations
22.
GRCh37:
Chr17:33427971-33428053
GRCh38:
Chr17:35100952-35101034
RAD51D, RAD51L3-RFFLT191fs, T303fs, T323fsBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(May 28, 2021)		criteria provided, single submitter
23.
GRCh37:
Chr17:33427972
GRCh38:
Chr17:35100953
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 10, 2019)		criteria provided, single submitter
24.
GRCh37:
Chr17:33427973
GRCh38:
Chr17:35100954
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 2, 2021)		criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr17:33427975
GRCh38:
Chr17:35100956
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Aug 31, 2021)		criteria provided, conflicting interpretations
26.
GRCh37:
Chr17:33427976
GRCh38:
Chr17:35100957
RAD51D, RAD51L3-RFFLT328I, T348I, T216Inot provided, Hereditary cancer-predisposing syndrome, not specified,
Breast-ovarian cancer, familial, susceptibility to, 4		Conflicting interpretations of pathogenicity
(Apr 6, 2023)		criteria provided, conflicting interpretations
27.
GRCh37:
Chr17:33427977
GRCh38:
Chr17:35100958
RAD51D, RAD51L3-RFFLT328A, T348A, T216ABreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Aug 24, 2021)		criteria provided, single submitter
28.
GRCh37:
Chr17:33427977
GRCh38:
Chr17:35100958
RAD51D, RAD51L3-RFFLT216S, T328S, T348Snot provided, Breast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndrome
Uncertain significance
(May 24, 2023)		criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr17:33427979
GRCh38:
Chr17:35100960
RAD51L3-RFFL, RAD51DQ347L, Q215L, Q327LBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Aug 31, 2021)		criteria provided, single submitter
30.
GRCh37:
Chr17:33427980
GRCh38:
Chr17:35100961
RAD51D, RAD51L3-RFFLQ327*, Q215*, Q347*Hereditary cancer-predisposing syndrome, not provided, Breast-ovarian cancer, familial, susceptibility to, 4
Uncertain significance
(Sep 13, 2022)		criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr17:33427982
GRCh38:
Chr17:35100963
RAD51L3-RFFL, RAD51DD326A, D346A, D214AHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Aug 28, 2021)		criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr17:33427985
GRCh38:
Chr17:35100966
RAD51L3-RFFL, RAD51DG213fs, G325fs, G345fsStomach cancerPathogenic
(Jul 1, 2021)		no assertion criteria provided
33.
GRCh37:
Chr17:33427985
GRCh38:
Chr17:35100966
RAD51D, RAD51L3-RFFLG325V, G213V, G345VBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Aug 27, 2021)		criteria provided, single submitter
34.
GRCh37:
Chr17:33427985
GRCh38:
Chr17:35100966
RAD51D, RAD51L3-RFFLG213D, G325D, G345Dnot providedUncertain significance
(Nov 27, 2019)		criteria provided, single submitter
35.
GRCh37:
Chr17:33427986
GRCh38:
Chr17:35100967
RAD51L3-RFFL, RAD51DG325R, G213R, G345RBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Jun 27, 2022)		criteria provided, single submitter
36.
GRCh37:
Chr17:33427986
GRCh38:
Chr17:35100967
RAD51D, RAD51L3-RFFLG325S, G213S, G345SHereditary cancer-predisposing syndrome, not specified, not provided,
Breast-ovarian cancer, familial, susceptibility to, 4, Hereditary breast ovarian cancer syndrome		Uncertain significance
(Jun 29, 2023)		criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr17:33427987
GRCh38:
Chr17:35100968
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeLikely benign
(Jul 17, 2018)		criteria provided, single submitter
38.
GRCh37:
Chr17:33427987
GRCh38:
Chr17:35100968
RAD51D, RAD51L3-RFFLQ324H, Q212H, Q344HHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Nov 13, 2022)		criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr17:33427988
GRCh38:
Chr17:35100969
RAD51D, RAD51L3-RFFLQ212L, Q324L, Q344LBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(May 3, 2021)		criteria provided, single submitter
40.
GRCh37:
Chr17:33427988
GRCh38:
Chr17:35100969
RAD51D, RAD51L3-RFFLQ212R, Q324R, Q344RBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 1, 2021)		criteria provided, single submitter
41.
GRCh37:
Chr17:33427989-33427990
GRCh38:
Chr17:35100970-35100971
RAD51L3-RFFL, RAD51DQ212fs, Q324fs, Q344fsBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 13, 2022)		criteria provided, single submitter
42.
GRCh37:
Chr17:33427990
GRCh38:
Chr17:35100971
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeLikely benign
(Aug 27, 2019)		criteria provided, single submitter
43.
GRCh37:
Chr17:33427991
GRCh38:
Chr17:35100972
RAD51D, RAD51L3-RFFLL323*, L343*, L211*Hereditary cancer-predisposing syndromeUncertain significance
(Jun 6, 2023)		criteria provided, single submitter
44.
GRCh37:
Chr17:33427991
GRCh38:
Chr17:35100972
RAD51L3-RFFL, RAD51DL343S, L211S, L323SHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Jul 25, 2021)		criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr17:33427991
GRCh38:
Chr17:35100972
RAD51D, RAD51L3-RFFLL323*, L343*, L211*Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 13, 2022)		criteria provided, single submitter
46.
GRCh37:
Chr17:33427991
GRCh38:
Chr17:35100972
RAD51D, RAD51L3-RFFLL211*, L323*, L343*Hereditary cancer-predisposing syndromeUncertain significance
(Apr 5, 2019)		criteria provided, single submitter
47.
GRCh37:
Chr17:33427992
GRCh38:
Chr17:35100973
RAD51D, RAD51L3-RFFLL211V, L323V, L343VBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeUncertain significance
(Sep 1, 2021)		criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr17:33427993
GRCh38:
Chr17:35100974
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4, not provided,
not specified		Likely benign
(Oct 12, 2022)		criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr17:33427995-33427996
GRCh38:
Chr17:35100976-35100977
RAD51L3-RFFL, RAD51DT322fs, T210fs, T342fsHereditary cancer-predisposing syndromeUncertain significance
(Mar 28, 2020)		criteria provided, single submitter
50.
GRCh37:
Chr17:33427996
GRCh38:
Chr17:35100977
RAD51L3-RFFL, RAD51DT342fs, T210fs, T322fsBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 13, 2022)		criteria provided, single submitter
51.
GRCh37:
Chr17:33427999
GRCh38:
Chr17:35100980
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeLikely benign
(Dec 4, 2020)		criteria provided, single submitter
52.
GRCh37:
Chr17:33427999-33428000
GRCh38:
Chr17:35100980-35100981
RAD51D, RAD51L3-RFFLA209fs, A321fs, A341fsnot provided, Hereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4
Uncertain significance
(Sep 13, 2022)		criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr17:33428000
GRCh38:
Chr17:35100981
RAD51D, RAD51L3-RFFLS208N, S340N, S320NHereditary cancer-predisposing syndromeUncertain significance
(Mar 30, 2023)		criteria provided, single submitter
54.
GRCh37:
Chr17:33428000
GRCh38:
Chr17:35100981
RAD51D, RAD51L3-RFFLS208T, S340T, S320TBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeUncertain significance
(Aug 9, 2022)		criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr17:33428000
GRCh38:
Chr17:35100981
RAD51D, RAD51L3-RFFLS320I, S340I, S208IBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 15, 2023)		criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr17:33428002
GRCh38:
Chr17:35100983
RAD51D, RAD51L3-RFFLQ207H, Q319H, Q339HBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Mar 5, 2022)		criteria provided, single submitter
57.
GRCh37:
Chr17:33428002
GRCh38:
Chr17:35100983
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndrome, not specified, not provided,
Breast-ovarian cancer, familial, susceptibility to, 4		Likely benign
(Nov 1, 2022)		criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr17:33428004
GRCh38:
Chr17:35100985
RAD51D, RAD51L3-RFFLQ319*, Q207*, Q339*not provided, Hereditary cancer-predisposing syndrome, not specified,
Breast-ovarian cancer, familial, susceptibility to, 4		Uncertain significance
(Oct 26, 2022)		criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr17:33428005
GRCh38:
Chr17:35100986
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeLikely benign
(May 24, 2022)		criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr17:33428006
GRCh38:
Chr17:35100987
RAD51L3-RFFL, RAD51DE338G, E318G, E206GHereditary cancer-predisposing syndromeUncertain significance
(Aug 23, 2018)		criteria provided, single submitter
61.
GRCh37:
Chr17:33428007
GRCh38:
Chr17:35100988
RAD51L3-RFFL, RAD51DE318K, E338K, E206KBreast-ovarian cancer, familial, susceptibility to, 4, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(May 23, 2022)		criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr17:33428009
GRCh38:
Chr17:35100990
RAD51D, RAD51L3-RFFLS337L, S205L, S317LHereditary cancer-predisposing syndromeUncertain significance
(Dec 21, 2020)		criteria provided, single submitter
63.
GRCh37:
Chr17:33428011
GRCh38:
Chr17:35100992
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeLikely benign
(Jun 15, 2021)		criteria provided, single submitter
64.
GRCh37:
Chr17:33428011
GRCh38:
Chr17:35100992
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Likely benign
(Oct 11, 2021)		criteria provided, single submitter
65.
GRCh37:
Chr17:33428012-33428013
GRCh38:
Chr17:35100993-35100994
RAD51D, RAD51L3-RFFLT204fs, T316fs, T336fsBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeUncertain significance
(Sep 13, 2022)		criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr17:33428014
GRCh38:
Chr17:35100995
RAD51L3-RFFL, RAD51DT204fs, T316fs, T336fsBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 13, 2022)		criteria provided, single submitter
67.
GRCh37:
Chr17:33428014
GRCh38:
Chr17:35100995
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeLikely benign
(Aug 20, 2022)		criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr17:33428015
GRCh38:
Chr17:35100996
RAD51D, RAD51L3-RFFLG315V, G335V, G203VHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Mar 10, 2023)		criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr17:33428015
GRCh38:
Chr17:35100996
RAD51D, RAD51L3-RFFLG315E, G335E, G203EBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeUncertain significance
(May 19, 2022)		criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:33428016
GRCh38:
Chr17:35100997
RAD51D, RAD51L3-RFFLG315R, G203R, G335RBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeUncertain significance
(Aug 31, 2021)		criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:33428017
GRCh38:
Chr17:35100998
RAD51D, RAD51L3-RFFLW202C, W314C, W334CBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Mar 19, 2022)		criteria provided, single submitter
72.
GRCh37:
Chr17:33428018
GRCh38:
Chr17:35100999
RAD51D, RAD51L3-RFFLW314S, W334S, W202SHereditary cancer-predisposing syndromeUncertain significance
(Dec 14, 2022)		criteria provided, single submitter
73.
GRCh37:
Chr17:33428018
GRCh38:
Chr17:35100999
RAD51D, RAD51L3-RFFLW202*, W314*, W334*Stomach cancerPathogenic
(Jul 1, 2021)		no assertion criteria provided
74.
GRCh37:
Chr17:33428019
GRCh38:
Chr17:35101000
RAD51L3-RFFL, RAD51DW314R, W202R, W334RHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Aug 24, 2022)		criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr17:33428020
GRCh38:
Chr17:35101001
RAD51L3-RFFL, RAD51DHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Likely benign
(Oct 1, 2021)		criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr17:33428020
GRCh38:
Chr17:35101001
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeLikely benign
(Nov 5, 2021)		criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr17:33428021
GRCh38:
Chr17:35101002
RAD51D, RAD51L3-RFFLT201S, T313S, T333SHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Jan 25, 2023)		criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr17:33428021
GRCh38:
Chr17:35101002
RAD51D, RAD51L3-RFFLT201N, T313N, T333NHereditary cancer-predisposing syndromeUncertain significance
(Jan 3, 2018)		criteria provided, single submitter
79.
GRCh37:
Chr17:33428023
GRCh38:
Chr17:35101004
RAD51D, RAD51L3-RFFLHereditary cancer-predisposing syndromeLikely benign
(Sep 8, 2022)		criteria provided, single submitter
80.
GRCh37:
Chr17:33428024
GRCh38:
Chr17:35101005
RAD51D, RAD51L3-RFFLG200E, G312E, G332EHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Aug 26, 2021)		criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr17:33428024
GRCh38:
Chr17:35101005
RAD51D, RAD51L3-RFFLG312A, G332A, G200AHereditary cancer-predisposing syndromeUncertain significance
(Jan 4, 2019)		criteria provided, single submitter
82.
GRCh37:
Chr17:33428024
GRCh38:
Chr17:35101005
RAD51D, RAD51L3-RFFLG200V, G312V, G332VHereditary cancer-predisposing syndromeUncertain significance
(Oct 21, 2018)		criteria provided, single submitter
83.
GRCh37:
Chr17:33428026
GRCh38:
Chr17:35101007
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Likely benign
(Oct 12, 2022)		criteria provided, single submitter
84.
GRCh37:
Chr17:33428026
GRCh38:
Chr17:35101007
RAD51D, RAD51L3-RFFLI311M, I199M, I331MHereditary cancer-predisposing syndromeUncertain significance
(Aug 9, 2021)		criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr17:33428027-33428035
GRCh38:
Chr17:35101008-35101016
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jan 11, 2023)		criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr17:33428027
GRCh38:
Chr17:35101008
RAD51D, RAD51L3-RFFLI311T, I199T, I331THereditary cancer-predisposing syndrome, not provided, Breast-ovarian cancer, familial, susceptibility to, 4
Uncertain significance
(Sep 14, 2022)		criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr17:33428027
GRCh38:
Chr17:35101008
RAD51D, RAD51L3-RFFLI311N, I199N, I331NBreast and/or ovarian cancer, Hereditary cancer-predisposing syndrome, not specified,
not provided, Breast-ovarian cancer, familial, susceptibility to, 4, Hereditary breast ovarian cancer syndrome
Conflicting interpretations of pathogenicity
(Aug 15, 2023)		criteria provided, conflicting interpretations
88.
GRCh37:
Chr17:33428028
GRCh38:
Chr17:35101009
RAD51D, RAD51L3-RFFLI199F, I311F, I331FHereditary cancer-predisposing syndromeUncertain significance
(Nov 16, 2022)		criteria provided, single submitter
89.
GRCh37:
Chr17:33428028
GRCh38:
Chr17:35101009
RAD51D, RAD51L3-RFFLI311L, I199L, I331LBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Oct 20, 2022)		criteria provided, single submitter
90.
GRCh37:
Chr17:33428028
GRCh38:
Chr17:35101009
RAD51D, RAD51L3-RFFLI311V, I199V, I331Vnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(May 23, 2022)		criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr17:33428029
GRCh38:
Chr17:35101010
RAD51D, RAD51L3-RFFLBreast-ovarian cancer, familial, susceptibility to, 4Likely benign
(Jul 20, 2022)		criteria provided, single submitter
92.
GRCh37:
Chr17:33428030
GRCh38:
Chr17:35101011
RAD51D, RAD51L3-RFFLD310G, D198G, D330GHereditary cancer-predisposing syndromeUncertain significance
(Nov 23, 2022)		criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr17:33428030
GRCh38:
Chr17:35101011
RAD51D, RAD51L3-RFFLD310A, D198A, D330AHereditary cancer-predisposing syndromeUncertain significance
(Feb 28, 2019)		criteria provided, single submitter
94.
GRCh37:
Chr17:33428034
GRCh38:
Chr17:35101015
RAD51D, RAD51L3-RFFLV197I, V309I, V329IHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Dec 12, 2022)		criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr17:33428034
GRCh38:
Chr17:35101015
RAD51D, RAD51L3-RFFLV309L, V197L, V329LHereditary cancer-predisposing syndromeUncertain significance
(Mar 6, 2019)		criteria provided, single submitter
96.
GRCh37:
Chr17:33428035-33428042
GRCh38:
Chr17:35101016-35101023
RAD51L3-RFFL, RAD51DQ306fs, Q326fs, Q194fsBreast-ovarian cancer, familial, susceptibility to, 4Uncertain significance
(Sep 13, 2022)		criteria provided, single submitter
97.
GRCh37:
Chr17:33428035
GRCh38:
Chr17:35101016
RAD51L3-RFFL, RAD51DM196I, M308I, M328IHereditary cancer-predisposing syndromeUncertain significance
(Mar 18, 2019)		criteria provided, single submitter
98.
GRCh37:
Chr17:33428035
GRCh38:
Chr17:35101016
RAD51D, RAD51L3-RFFLM308I, M196I, M328IHereditary cancer-predisposing syndromeUncertain significance
(Jun 10, 2016)		criteria provided, single submitter
99.
GRCh37:
Chr17:33428037
GRCh38:
Chr17:35101018
RAD51D, RAD51L3-RFFLM196L, M308L, M328LBreast-ovarian cancer, familial, susceptibility to, 4, Hereditary cancer-predisposing syndromeUncertain significance
(Apr 21, 2022)		criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr17:33428037
GRCh38:
Chr17:35101018
RAD51D, RAD51L3-RFFLM308V, M196V, M328VHereditary cancer-predisposing syndrome, Breast-ovarian cancer, familial, susceptibility to, 4Conflicting interpretations of pathogenicity
(Oct 1, 2022)		criteria provided, conflicting interpretations
Display optionsSort by LocationDownload
Format
Items per page
Sort by
Choose Destination